You are here

cancer

AstraZeneca pivots to early-stage cancer in search of a niche

Fierce Pharma

Tue, 05/28/19 - 10:31 am

Ideaya wraps $50M IPO to fuel clinical drive on synthetic lethality

Endpoints

Fri, 05/24/19 - 10:50 am

Dynavax cuts staff in retreat from cancer research

Biopharma Dive

Fri, 05/24/19 - 10:43 am

Dynavax Technologies

Affimed scraps T-cell engager program, parts company with CSO

Fierce Biotech

Thu, 05/23/19 - 11:06 pm

bispecific antibodies

Can AI Tools Segment A Cancer Tumor As Well As An Oncologist?

Forbes

Tue, 05/21/19 - 09:43 am

artificial intelligence

cancer radiation therapy

Commentary: Novartis CEO: Gene therapy offers hope of cures in one treatment, but US needs new pricing and payment model

CNBC

Fri, 05/17/19 - 07:21 pm

Actuate raises $22M to expand GSK-3β cancer trial

Fierce Biotech

Fri, 05/17/19 - 01:06 pm

Acutate Therapeutics

clinical trials

Grail, the liquid biopsy startup, picks an approach for its cancer test

Stat

Mon, 05/13/19 - 08:18 pm

clinical trials

New Eisai venture arm to focus on digital tech, dementia, cancer

BioCentury

Fri, 05/10/19 - 06:02 pm

venture capital

digital technology

Novartis sees Saudi Arabia as promising market for producing its cancer drugs

Fierce Pharma

Thu, 05/9/19 - 11:04 am

Amgen, Syapse enter precision medicine collaboration in oncology

Pharmaceutical Business Review

Fri, 05/3/19 - 10:46 am

precision medicine

Tessa showcases preclinical promise of 'all-in-one' add-on to its cancer cell therapy, in march to the clinic

Endpoints

Fri, 05/3/19 - 10:22 am

Tessa Therapeutics

virally-associated tumors

Caris aims to bridge gap between patients, precision trials with Pharmatech takeout

BioCentury

Thu, 05/2/19 - 10:15 am

molecular profiling

drug development

precision medicine

clinical trials

CMS reopens coverage determination on next-gen sequencing for cancer patients

Medtech Dive

Tue, 04/30/19 - 09:43 pm

next generation sequencing

Can 'synthetic lethality' and deep experience propel this cancer-fighting biotech's $70M IPO?

Bizjournals

Tue, 04/30/19 - 09:37 am

The entrepreneur behind the cancer immunotherapy revolution

Stat

Mon, 04/29/19 - 09:39 am

3 Cancer Treatment Stocks on a Growth Trend

Motley Fool

Sun, 04/21/19 - 10:33 pm

A biotech startup’s lofty goal: Kill cancer with pills that target RNA instead of proteins

Stat

Thu, 04/18/19 - 11:04 am

Arrakis Therapeutics

First U.S. Patients Treated With CRISPR As Gene-Editing Human Trials Get Underway

NPR

Tue, 04/16/19 - 11:14 am

5 things to know about Hookipa Pharma ahead of its IPO

Marketwatch

Fri, 04/12/19 - 10:03 am

infectious diseases

Pages